Lizzo, the singer and flutist behind Billboard chart-toppers like “Truth Hurts” and “About Damn Time,” has shared a lot with ...

The pecking order of the obesity drug market is shifting. Eli Lilly , the $815 billion maker of blockbuster weight-loss drugs ...

Skye Bioscience currently trades essentially at cash value, meaning investors who buy in today get a weight loss drug ...

Viking Therapeutics, Inc.'s VK2735 has potential as a GLP-1 for obesity amid Pfizer's exit, but competition and financing ...

Tracye Craven, 65, was at her highest weight after losing her job and her father — but a wake-up call at the doctor led her to prioritize her health and look past her 'real good excuses' to get ...

The virtual nutrition care startup just raised a $70 million Series B funding round, and it's profitable, BI has learned ...

Danish drugmaker Novo Nordisk A/S (CPH: NOVO-B) lost more than 10% last week after its US rival Eli Lilly & Co (NYSE: LLY) reported encouraging Phase 3 data for its oral weight-loss treatment. ...

Drugs firms argue that NICE ’s thresholds are too stingy. Medicines made up around 9% of health spending in Britain in 2018, ...

Lizzo has revealed how she dropped a whopping 16% of her body fat during a TikTok livestream on Tuesday — months after ...

Startup Brellium built an artificial-intelligence-powered solution that helps providers automate clinical quality and payer ...

Shares of Pfizer Inc (NYSE:PFE) dipped 1.5% as the pharmaceutical giant announced the discontinuation of its drug candidate danuglipron, which was under investigation for chronic weig... "Kalkine ...